BACKGROUND: The effect of peripheral arterial disease (PAD) on outcomes in patients with chronic heart failure (HF) has not been examined in propensity-matched studies. METHODS AND RESULTS: Of the 2689 patients with advanced chronic systolic HF in the Beta-Blocker Evaluation of Survival Trial, 441 had a history of PAD. Propensity scores for a history of PAD, calculated for each patient using a multivariable logistic regression model, were used to assemble a matched cohort of 299 and 1015 patients, respectively, with and without PAD who were well balanced on 65 measured baseline characteristics. Cox regression models were used to estimate hazard ratios and 95% CIs for associations between PAD and outcomes during 4.1 years of follow-up. Patients had a mean age of 63+/-11 years, 19% were women, and 19% were black. All-cause mortality occurred in 43% and 33% of patients with and without a history of PAD, respectively (hazard ratio when PAD was compared with no history of PAD, 1.40; 95% CI, 1.14 to 1.72; P=0.001). All-cause hospitalization occurred in 75% and 63% of patients with and without PAD, respectively (hazard ratio when PAD was compared with no history of PAD, 1.36; 95% CI, 1.16 to 1.58; P<0.0001). PAD-associated hazard ratios for cardiovascular mortality, HF mortality, and HF hospitalization were 1.31 (95% CI, 1.04 to 1.63; P=0.019), 1.40 (95% CI, 0.97 to 2.02; P=0.076), and 1.05 (95% CI, 0.86 to 1.29; P=0.635), respectively. CONCLUSIONS: In a well-balanced propensity-matched population of chronic systolic HF patients, a history of PAD was independently associated with increased mortality and hospitalization.
BACKGROUND: The effect of peripheral arterial disease (PAD) on outcomes in patients with chronic heart failure (HF) has not been examined in propensity-matched studies. METHODS AND RESULTS: Of the 2689 patients with advanced chronic systolic HF in the Beta-Blocker Evaluation of Survival Trial, 441 had a history of PAD. Propensity scores for a history of PAD, calculated for each patient using a multivariable logistic regression model, were used to assemble a matched cohort of 299 and 1015 patients, respectively, with and without PAD who were well balanced on 65 measured baseline characteristics. Cox regression models were used to estimate hazard ratios and 95% CIs for associations between PAD and outcomes during 4.1 years of follow-up. Patients had a mean age of 63+/-11 years, 19% were women, and 19% were black. All-cause mortality occurred in 43% and 33% of patients with and without a history of PAD, respectively (hazard ratio when PAD was compared with no history of PAD, 1.40; 95% CI, 1.14 to 1.72; P=0.001). All-cause hospitalization occurred in 75% and 63% of patients with and without PAD, respectively (hazard ratio when PAD was compared with no history of PAD, 1.36; 95% CI, 1.16 to 1.58; P<0.0001). PAD-associated hazard ratios for cardiovascular mortality, HF mortality, and HF hospitalization were 1.31 (95% CI, 1.04 to 1.63; P=0.019), 1.40 (95% CI, 0.97 to 2.02; P=0.076), and 1.05 (95% CI, 0.86 to 1.29; P=0.635), respectively. CONCLUSIONS: In a well-balanced propensity-matched population of chronic systolic HFpatients, a history of PAD was independently associated with increased mortality and hospitalization.
Authors: Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori Journal: N Engl J Med Date: 2001-05-31 Impact factor: 91.245
Authors: Ali Ahmed; Richard M Allman; Gregg C Fonarow; Thomas E Love; Faiez Zannad; Louis J Dell'italia; Michel White; Mihai Gheorghiade Journal: J Card Fail Date: 2008-04 Impact factor: 5.712
Authors: Mary McGrae McDermott; Jack M Guralnik; Philip Greenland; William H Pearce; Michael H Criqui; Kiang Liu; Lloyd Taylor; Cheeling Chan; Leena Sharma; Joseph R Schneider; Paul M Ridker; David Green; Maureen Quann Journal: Circulation Date: 2003-02-11 Impact factor: 29.690
Authors: Tracie C Collins; Susan K Ewing; Susan J Diem; Brent C Taylor; Eric S Orwoll; Steven R Cummings; Elsa S Strotmeyer; Kristine E Ensrud Journal: Circulation Date: 2009-04-20 Impact factor: 29.690
Authors: Michael H Criqui; John K Ninomiya; Deborah L Wingard; Ming Ji; Arnost Fronek Journal: J Am Coll Cardiol Date: 2008-11-18 Impact factor: 24.094
Authors: Jorge Silva Enciso; Tomoko S Kato; Zhezhen Jin; Christine Chung; Jonathan Yang; Hiroo Takayama; Donna M Mancini; P Christian Schulze Journal: Am J Cardiol Date: 2014-07-17 Impact factor: 2.778
Authors: W Schuyler Jones; Robert Clare; Stephen J Ellis; James S Mills; David L Fischman; William E Kraus; David J Whellan; Christopher M O'Connor; Manesh R Patel Journal: Am J Cardiol Date: 2011-05-10 Impact factor: 2.778
Authors: Elizabeth Kvale; O James Ekundayo; Yan Zhang; Shamima Akhter; Inmaculada Aban; Thomas E Love; Christine Ritchie; Ali Ahmed Journal: Cancer Epidemiol Date: 2010-08-13 Impact factor: 2.984
Authors: Linda G Jones; Mo-Kyung Sin; Fadi G Hage; Raya E Kheirbek; Charity J Morgan; Michael R Zile; Wen-Chih Wu; Prakash Deedwania; Gregg C Fonarow; Wilbert S Aronow; Sumanth D Prabhu; Ross D Fletcher; Ali Ahmed; Richard M Allman Journal: Circ Heart Fail Date: 2014-12-05 Impact factor: 8.790